Loss of myoepithelium is variable in solid papillary carcinoma of the breast

Histopathology

Volumn 51, Issue 5, 2007, Pages 657-665

  Nicolas, M M ^a   Wu, Y ^a   Middleton, L P ^a   Gilcrease, M Z ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast; Myoepithelium; Solid papillary carcinoma

Indexed keywords

EOSIN; HEMATOXYLIN; PROTEIN P63; SMOOTH MUSCLE ACTIN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; BREAST METASTASIS; CANCER CYTODIAGNOSIS; CANCER GROWTH; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MICROMETASTASIS; MYOEPITHELIUM CELL; PAPILLARY CARCINOMA; PRIORITY JOURNAL; TISSUE SECTION;

AGED; BREAST; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, PAPILLARY; EPITHELIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 35348917199     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02849.x     Document Type: Article

References (22)

1. Maluf HM, Koerner FC. Solid papillary carcinoma of the breast. A form of intraductal carcinoma with endocrine differentiation frequently associated with mucinous carcinoma. Am. J. Surg. Pathol. 1995 19 1237 1244.
2. Tsang WY, Chan JK. Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics. Am. J. Surg. Pathol. 1996 20 921 943.
3. Rosen PP. Papillary carcinoma. In Rosen PP ed. Rosen's breast pathology, 2nd edn. Philadelphia : Lippincott Williams and Wilkins, 2001 381 404.
4. Tavassoli FA. Papillary lesions. In Tavassoli FA ed. Pathology of the breast. New York : McGraw-Hill, 1999 325 372.
5. MacGrogan G, Moinfar F, Raju U. Intraductal papillary neoplasms. In : Tavassoli FA, Devilee P, eds. Pathology and genetics of tumours of the breast and female genital organs. Lyon : IARC Press, 2003.
6. Zamecnik M. Mixed solid papillary and mucinous carcinoma of the breast. Ultrastruct. Pathol. 1998 22 165 166.
7. Cserni G. "Revertant" mammary solid papillary carcinoma in lymph node metastasis. Pathol. Oncol. Res. 2002 8 74 77.
8. Dickersin GR, Maluf HM, Koerner FC. Solid papillary carcinoma of breast: an ultrastructural study. Ultrastruct. Pathol. 1997 21 153 161.
9. Collins LC, Carlo VP, Hwang H et al. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers. Am. J. Surg. Pathol. 2006 30 1002 1007.
10. Barbareschi M, Pecciarini L, Cangi MG et al. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am. J. Surg. Pathol. 2001 25 1054 1060.
11. Lazard D, Sastre X, Frid MG et al. Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc. Natl Acad. Sci. U.S.A. 1993 90 999 1003.
12. Lagios MD. Duct carcinoma in situ: pathology and treatment. Surg. Clin. North Am. 1990 70 853 871.
13. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer: I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991 19 403 410.
14. Carter D, Orr SL, Merino MJ. Intracystic papillary carcinoma of the breast after mastectomy, radiotherapy or excisional biopsy alone. Cancer 1983 52 14 19.
15. Nassar H, Qureshi H, Volkanadsay N et al. Clinicopathologic analysis of solid papillary carcinoma of the breast and associated invasive carcinomas. Am. J. Surg. Pathol. 2006 30 501 507.
16. Page DL, Dixon JM, Anderson TJ et al. Invasive cribriform carcinoma of the breast. Histopathology 1983 7 525 536.
17. Samaratunga H, Singh M. Distribution pattern of basal cells detected by cytokeratin 34 beta E12 in primary prostatic duct adenocarcinoma. Am. J. Surg. Pathol. 1997 21 435 440.
18. Prioleau PG, Santa Cruz DJ, Meyer JS et al. Verrucous carcinoma: a light and electron microscopic, autoradiographic, and immunofluorescence study. Cancer 1980 45 2849 2857.
19. Barsky SH, Doberneck SA, Sternlicht MD et al. 'Revertant' DCIS in human axillary breast carcinoma metastases. J. Pathol. 1997 183 188 194.
20. Weaver VM, Petersen OW, Wang F et al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol. 1997 137 231 245.
21. Charpin C, Lissitzky JC, Jacquemier J et al. Immunohistochemical detection of laminin in 98 human breast carcinomas: a light and electron microscopic study. Hum. Pathol. 1986 17 355 365.
22. Davis TL, Cress AE, Dalkin BL et al. Unique expression pattern of the alpha6beta4 integrin and laminin-5 in human prostate carcinoma. Prostate 2001 46 240 248.